___

• 1. WHO, Prevention of Hospital-Acquired Infections: a Practical Guide, 2nd edition, document WHO/CDS/CSR/EPH/2002/12, Geneva: World Health Organization. 2002; 1-64. 2. Danasekaran GMR, Annadurai K. Prevention of healthcare-associated infections: protecting patients, saving lives. Int J Com Med Public Health 2014; 1(1): 67-8. 3. WHO, The burden of health care-associated infection worldwide, 2016 [Online] Available from: http://www.who.int/gpsc/country_work/burden_hcai/en/ 4. Meyer B, Cookson B. Does microbial resistance or adaptation to biocides create a hazard in infection prevention and control? J Hosp Infect 2010; 76(3): 200-5. 5. Khan HA, Ahmad A, Mehboob R. Nosocomial infections and their control strategies. Asian Pac J Trop Biomed 2015; 5(7): 509-14. 6. Horan TC, Andrus M, Dudeck MA. CDC/NHSN surveillance definition of health care-associated infection and criteria for specific types of infections in the acute care setting. Am J Infect Control 2008; 36(5): 309-32. 7. Dancer SJ. How do we assess hospital cleaning? A proposal for microbiological standards for surface hygiene in hospitals. J Hosp Infect 2004; 56(1): 10-5. 8. Carling PC, Parry MM, Rupp ME, Po JL, Dick B, Von Beheren S. Improving cleaning of the environment surrounding patients in 36 acute care hospitals. Infect Control Hosp Epidemiol 2008; 29(11): 1035-41. 9. Oule´MK, Azinwi R, Bernier AM, Kablan T, Maupertuis AM, Mauler S, et al. Polyhexamethylene guanidine hydrochloride-based disinfectant: a novel tool to fight meticillin-resistant Staphylococcus aureus and nosocomial infections. J Med Microbiol 2008; 57: 1523-8. 10. Maillard JY. Bacterial resistance to biocides in the healthcare environment: should it be of genuine concern? J Hosp Infect 2007; 65(S2): 60-72. 11. Taralp A, Menceloglu Y, Simsek, E, Acatay K. WO 2011132020 A1, Preparation of substantially quaternized ammonium organosilane composition and self-stabilizing aqueous solution thereof; 2011. 12. USEPA/OPP; Trimethoxysilyl Quaternary Ammonium Chloride Preliminary Workplan. Regristration Review. EPA-HQ-OPP-2013-0095. March 4, 2016; Available from: https://iaspub.epa.gov/apex/pesticides/f?p=chemicalsearch:1 13. Sanli-Yurudu NO, Kimiran-Erdem A, Cotuk A. Studies on the efficacy of chloramine t trihydrate (N-chloro-p-toluene sulfonamide) against planktonic and sessile populations of different Legionella pneumophila strains. Int J Hyg Environ Health 2007; 210(2): 147-53. 14. CLSI Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically; approved standard-Ninth Edition. CLSI document M07-A9. Wayne, PA: Clinical and Laboratory Standards Institute; 2012. 15. European Committee for standardization European standard BS EN 1276: Chemical disinfectants and antiseptics-Quantitative suspension test for evaluation of bactericidal activity of chemical disinfectants and antiseptics used in food, industrial, domestic and institutional areas. Test method and requirements (phase 2, step 1); 2009. 16. Rodriguez GG, Phipps D, Ishiguro K and Ridgway HF. Use of a fluorescent redox probe for direct visualization of actively respiring bacteria. Applied and Environmental Microbiology 1992; 58: 1801-08. 17. Sanli-Yurudu NO. Study of biofilm associated bacteria on polyvinyl chloride, stainless steel and glass surfaces in a model cooling tower system with different microbiological methods. IUFS Journal of Biology 2012; 71(1): 63-76. 18. Inweregbu K, Dave J, Pittard A. Nosocomial infections. Continuing Education in Anaesthesia Crit Care Pain 2005; 5(1): 14-7. 19. Revelas A. Healthcare–associated infections: A public health problem. Niger Med J 2012; 53(2): 59-64. 20. Yüceer S, Guler Demir S. Prevention of nosocomial infections in intensive care unit and nursing practices. Dicle Med J 2009; 36(3): 226-32. 21. Bereket W, Hemalatha K, Getenet, B, Wondwossen T, Solomon A, Zeynudin A, et al. Update on bacterial nosocomial infections. Eur Rev Med Pharmacol Sci 2012; 16(8): 1039-44. 22. Kölgelier S, Kucuk A, Demir NA, Ozcimen S, Demir LS. Nosocomial Infections in Intensive Care Units: Etiology and Predisposing Factors. Kafkas J Med Sci 2012; 2(1): 1-5. 23. Dancer SJ, The role of environmental cleaning in the control of hospital-acquired infection. J Hosp Infect 2009; 73(4): 378-85. 24. Abreu AC, Tavares RR, Borges A, Mergulhão F, Simões M. Current and emergent strategies for disinfection of hospital environments. J Antimicrob Chemoter 2013; 68(12): 2718-32. 25. El-Mahmood AM, Doughari JH, Bacteriological examination of some diluted disinfectants routinely used in the Specialist Hospital Yola. Nigeria Afr J Pharm Pharmacol 2009; 3(5): 185-90. 26. Harbarth S, Tuan Soh S, Horner C, Wilcox MH. Is reduced susceptibility to disinfectants and antiseptics a risk in healthcare settings? A point/ counterpoint review. J Hosp Infext 2014; 87(4): 194-202. 27. Oliver JD. The viable but nonculturable state in bacteria. J Microbiol 2005; 43: 93-100. 28. Dogruoz-Gungor N, Sanli-Yurudu NO. Evaluation of bacterial resistance to Chloramine T and effects on rifampicin susceptibility as a consequence of biocide usage in Cooling System Biofilm, Méndez-Vilas A. (Editor) The Battle Against Microbial Pathogens: Basic Science, Technological Advances and Educational Programs” (Microbiology Book Series, number #5), Chapter 10, Formatex Research Center, Badajoz, Spain, 2015; pp. 923-929, ISBN-13 Vol. 2: 978-84-942134-7-2.